Article
AON Announces Dr Stephen “Fred” Divers as New Chief Medical Officer
American Oncology Network (AON) announced the appointment of Stephen "Fred" Divers, MD, a medical oncologist with Genesis Cancer and Blood Institute, as its new chief medical officer.
Fort Myers, Florida — American Oncology Network (AON) announced today, May 18, that Stephen "Fred" Divers, a medical oncologist with Genesis Cancer and Blood Institute, will serve as its new chief medical officer (CMO).
As CMO, Divers will play a vital role in furthering AON’s mission, providing leadership, strategy, and vision around practice transformation ensuring that its clinical model addresses patient needs. In addition to his new role as CMO, Dr. Divers will continue as AON Advisory Board Chairman and see patients at Genesis Cancer and Blood Institute.
“We are thrilled to announce Dr. Divers as our CMO,” said Todd Schonherz, chief executive officer, AON. “Since AON’s inception and as chairman of the AON Advisory Board, Dr Divers has been instrumental in leading the charge on ensuring patients have ready access to affordable, high quality cancer care in their local communities."
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
